Asteria Health Recalls Testosterone and Anastrozole Sterile Pellets Due to Potential Metal Contamination
F.H. INVESTMENTS, Inc. (dba Asteria Health) has issued a voluntary recall for Testosterone and Anastrozole sterile pellets due to the potential presence of metal particulate matter.
What Happened
F.H. INVESTMENTS, Inc., doing business as Asteria Health, has initiated a voluntary recall of specific sterile pellets containing Testosterone and Anastrozole. The recall was triggered by the discovery of a foreign substance, specifically the potential presence of metal particulate matter, within the product. This recall has been classified as Class II by the FDA.
Which Products Are Affected
The recall involves 100 units of the following product:
- Product Name: Testosterone 100mg, Anastrozole 4mg (4.5), 1 Sterile Pellet
- Brand: Asteria Health
- NDC: 79559-4104-01
- Lot Number: 254000104
- Expiration Date: 05/27/2026
These products were distributed nationwide across the United States.
What You Should Do
Consumers and healthcare professionals should immediately stop using the affected lot. The firm initiated the recall via letter on January 26, 2026. For further information regarding returns or specific medical concerns, consumers may contact F.H. INVESTMENTS, Inc. (dba Asteria Health) at their Birmingham, Alabama facility located at 432 Industrial Ln, Birmingham, AL 35211-4465.
Why This Matters
The presence of foreign metal particulates in a sterile pellet intended for medical use poses a serious health risk, as it can lead to local inflammation, irritation, or other complications at the site of administration.
Source
Information provided by the FDA under Recall Number D-0326-2026.
Source: FDA Official Notice